CorrlensCorrlens
Correlate

Correlation Analysis

Nvidia Corp vs Alnylam Pharmaceuticals, Inc.

NVDA vs ALNY

+0.825

Strong positive

When one moves up, the other tends to follow.

NVDA logo

Nvidia Corp

NVDA

Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence to run large language models. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.

Market cap 4.3T

ALNY logo

Alnylam Pharmaceuticals, Inc.

ALNY

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.

Market cap 43.8B · 2,500 employees

Apr 9, 2021 — Apr 7, 2026Daily1,253 observationsStockStockTechnology

Who Moves First

NVDA leads ALNY by 6 days

NVDA tends to move before ALNY.

Best correlation after shifting: +0.826 (13 shifts scanned)

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.046

14 periods · Return correlation when both series rose

Both Falling

+0.303

8 periods · Return correlation when both series fell

Diverging

-0.367

13 periods · Return correlation when series moved apart

R-Squared

68.1%

Share of variance in one series explained by the other.

Trend Agreement

56.2%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,253

Deep shared window — 1,253 usable pairs.

Significance

p < 0.001

95% CI: [0.807, 0.842]

Time Series

Rebased to 100

Green: NVDAGray: ALNY36 of 1,253 points (sampled)

Scatter

XY Regression

-1.305010015020021898100200300400497Nvidia CorpAlnylam Pharmaceuticals, Inc.Data pointsFit (r = 0.825)

Pipeline

Data quality details

Pipeline Summary

1,253 paired observations survived the daily window.

Raw input

1,254

1,253

Normalized

1,254

1,253

Prepared

1,254

1,253

Aligned

1,253

1,253

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

1

A: 1 / B: 0

Series A

NVDA logo

Nvidia Corp

NVDA

Market cap 4.3T

Stock · 1,254 raw → 1,254 prepared

Series B

ALNY logo

Alnylam Pharmaceuticals, Inc.

ALNY

Market cap 43.8B · 2,500 employees

Stock · 1,253 raw → 1,253 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

72

Estimated crossover points between normalized spreads.

Slope

1.1536

Linear regression slope.

Intercept

141.1342

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 3 hours ago · ID: stock-nvda-vs-stock-alny-daily-20260408-93ea73